News

Pharmabiz15h
KPRDO concerned over JAKs selling other branded generic drugs in violation of Clause 2.4 of PMBI agreement
Nandita Vijayasimha, Bengaluru Tuesday, July 29, 2025, 08:00 Hrs [IST] ...
Pharmabiz7h
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC: Honk Kong Tuesday, July 29, 2025, 16:00 Hrs [IST] Akeso, Inc., ...
Pharmabiz6h
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore: Singapore Tuesday, July 29, 2025, 17:00 Hrs [IST] Elpis ...
Pharmabiz7h
Fortis and Agilus expand rapid genomic testing capabilities with launch of second Genexus System
Fortis and Agilus expand rapid genomic testing capabilities with launch of second Genexus System: Our Bureau, Bengaluru Tuesday, July 29, 2025, 16:15 Hrs [IST] Fortis Memorial Res ...
Pharmabiz11h
Hengrui Pharma enters agreement and with GSK to develop up to 12 innovative medicines across respiratory, immunology & inflammation & oncology
Hengrui Pharma enters agreement and with GSK to develop up to 12 innovative medicines across respiratory, immunology & inflammation & oncology: Jiangsu, China Tuesday, July 29, 20 ...
Pharmabiz13h
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC: Basel Tuesday, July 29, 2025, 10:00 Hrs [IST] Roche ann ...
Pharmabiz9h
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Pharmabiz14h
UK MHRA approves Biogen Netherlands’ tofersen to treat rare inherited form of motor neurone disease
UK MHRA approves Biogen Netherlands’ tofersen to treat rare inherited form of motor neurone disease: United Kingdom Tuesday, July 29, 2025, 09:00 Hrs [IST] The Medicines and Hea ...
Pharmabiz11h
Pristine Eye Hospitals to set up Centre of Excellence for Dry Eye, to combat digital eye strain crisis on July 30
Pristine Eye Hospitals to set up Centre of Excellence for Dry Eye, to combat digital eye strain crisis on July 30: Our Bureau, Bengaluru Tuesday, July 29, 2025, 12:45 Hrs [IST] Pr ...
Pharmabiz10h
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...
Pharmabiz10h
L V Prasad Eye Institute study notes elderly undergoing cataract surgery lack medical insurance support
L V Prasad Eye Institute study notes elderly undergoing cataract surgery lack medical insurance support: Our Bureau, Bengaluru Tuesday, July 29, 2025, 13:15 Hrs [IST] L V Prasad E ...
Pharmabiz8h
BPL Medical Technologies chief notes inking India-UK FTA to propel growth
BPL Medical Technologies chief notes inking India-UK FTA to propel growth: Our Bureau, Bengaluru Tuesday, July 29, 2025, 15:30 Hrs [IST] BPL Medical Technologies managing director ...